喘管理中的高CBD提取物 (CBD-X):降低Th2-驱动的细胞因子分泌和中性粒细胞/乙氨基粒细胞活动
Miran Aswad1,2, Antonina Pechkovsky1,2, Narmeen Ghanayiem1,2
1Medical Cannabis Research and Innovation Center, Rambam Health Care Campus, Haifa 3109601, Israel.
Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
概括
大麻素提取物 (CBD-X) 通过减少关键的炎症标志物和免疫细胞活性,对喘治疗有希望. 这可能为管理2型高喘和2型低喘提供一种新的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘在全球影响超过10%,其特点是气道炎症和高反应性.
- 2型低喘通常对标准的吸入性皮质类固醇 (ICS) 治疗具有抗性.
- 大麻二醇 (CBD) 以其抗炎性质和免疫调节潜力而闻名.
研究的目的:
- 为了研究高含量大麻素提取物 (CBD-X) 在喘中的治疗潜力.
- 为了评估CBD-X对免疫细胞的作用,CBD-X对免疫细胞的作用是喘发病的核心.
- 在临床前喘模型中评估CBD-X的疗效.
主要方法:
- 使用了原始的人类Th2细胞和中性粒细胞.
- 他们使用了一种喘的小鼠模型.
- 分析了CBD-X对细胞因子分泌,细胞分化和迁移的影响.
主要成果:
- CBD-X 抑制了 Th2 细胞分化,并降低了与喘相关的关键细胞因子 (IL-5,IL-13).
- 在中性粒细胞中,CBD-X降低了促炎性细胞因子 (IL-8,IL-6),并影响了它们的迁移.
- 在小鼠模型中,CBD-X降低了IgE,促喘细胞因子的调节,并减少了肺部炎症细胞的透.
结论:
- CBD-X显示出与喘相关的显著抗炎作用.
- 提取物调节关键的免疫通路,涉及2型高喘和2型低喘.
- CBD-X为喘管理提供了一个潜在的新疗法策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
01:24Antiasthma Drugs: Methylxanthines
199
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
199
01:19Antiasthma Drugs: Leukotriene Modifiers
246
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
246
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:20Asthma: Pathogenesis and Management
361
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
361